SOSabína Oreská

Sabína Oreská

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sabína Oreská has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in plasma concentration of cell-free DNA as a response to physical activity

    by Jaroslav Alois Hubacek, Dana Dlouhá, Hana Wünsch, Kryštof Slabý, Sabína Oreská, Aneta Prokopcová, Marian Rybář, Michal Vrablík, Michal Tomčík

    Introduction: Plasma concentrations of cell-free DNA (cfDNA) serve as markers of overtraining or muscle injury. We have examined, if nuclear (n) and mitochondrial (mt) cfDNA has the potential as a marker of muscle burden or damage.Material and methods: Ten healthy, physically active volunteers (6 females, aged 27.1±6.8 years) performed a downhill running test. Samples for cfnDNA and cfmtDNA analysis were collected before, 30 minutes, 1 hour, and 14 days after the downhill run. CfnDNA and cfmtDNA (two markers for both) were analysed using qPCR.Results: There was an extreme (~ 40-times) increase in cfnDNA at the 30-min time-point against the baseline (p<0.00001 for both markers), followed by a quick drop to baseline levels after 1 hour after the end of the downhill run for all subjects. In contrast, plasma levels of cfmtDNA did not increase significantly (p=0.27 and 0.12). It reflects the fact, that in 6 subjects, the pattern was similar as for cfnDNA but in 4 subjects rather a decrease of cfmtDNA concentration was observed at the 30-mi time-point. These differences correlate with age, BMI, and sex of the participants. Plasma cfnDNA significantly (p<0.01 for all) correlated with concentrations of muscle damage markers such as AST, ALT, and lactate dehydrogenase, and chemokines MIP-1α and IP-10 (positive). No homogenous correlation between cfmtDNA and biomarkers was detected.Conclusions: Our study confirms the extreme release and clearance of cfnDNA in physically active subjects after strenuous exercise. In contrast, the trajectory of cfmtDNA concentrations seems to have much higher inter-individual variability than cfnDNA concentrations.

  • CRTAC1: a novel indicator of lung involvement in SSc

    by Aneta Prokopcova, Sabina Oreska, Hana Wunsch, Jiri Baloun, Radim Becvar, Ladislav Senolt, Michal Tomcik

    Objectives: Interstitial lung disease (ILD) is the most frequent cause of mortality in patients with SSc. Cartilage acidic protein-1 (CRTAC1), secreted by alveolar type-2 epithelial cells, is a potential biomarker of lung health. This study explores CRTAC1’s role in SSc, focusing on pulmonary involvement. Methods: We collected plasma samples from 76 SSc patients (65 females, limited cutaneous (lc)SSc: 45, diffuse cutaneous (dc)SSc: 31, ILD: 43, all fulfilled the 2013 ACR/EULAR criteria) and 89 healthy individuals (HC, 37 females). Patients were examined and assessed for the European Scleroderma Study Group (ESSG) activity score, modified Rodnan skin score (mRSS), forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), diffusing capacity for carbon monoxide (DLCO) and Medsger Disease Severity Scale (DSS). CRTAC1 levels were measured using the CRTAC1 IQ-ELISA (Ray Biotech). Results: CRTAC1 levels in plasma were lower in SSc patients compared with HC (P < 0.001). CRTAC1 was decreased in SSc patients with ILD compared with SSc patients without ILD (P = 0.027). Linear modelling showed negative association of CRTAC1 with DSS pulmonary involvement (P = 0.016, β = −2.46) and ESSG activity score (P = 0.047, β = −2.022), and a positive association with DLCO (P = 0.065, β = 1.87), FEV1 (P = 0.1, β = 1.622) and FVC (P = 0.072, β = 1.83). CRTAC1 levels were also decreased in SSc patients with gastrointestinal (P = 0.002) and joint (P = 0.006) involvement and pulmonary arterial hypertension (P = 0.05). Conclusion: Systemic levels of CRTAC1 are decreased in SSc patients, especially among those with ILD, reduced lung function and elevated disease activity. Our findings establish CRTAC1 as a promising biomarker for pulmonary involvement in SSc.


  • Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training

    by Nikoleta Alchus Laiferová, Lucia Vernerová, Michal Nemec, Daria Barkova, Katarína Rerková, Karin Marček Malenovská, Martina Vokurková, Sabína Oreská, Martin Klein, Maja Špiritović, et al.

    Objective: The objective of this work was to examine myomiR levels in plasma, skeletal muscle, and skeletal muscle cells of patients with idiopathic inflammatory myopathy (IIM), and their interrelations with the disease-related clinical phenotypes and with the effects of a disease-modifying 6-months-training intervention. Methods: Samples of vastus lateralis muscle (n = 12/13) and plasma (n = 21/20) were obtained from IIM patients and healthy controls, respectively. The muscle and plasma samples were obtained before and after a 6-months training intervention in 7 patients. MyomiRs miR-1, -206, -133a, and -133b were quantified using quantitative PCR (qPCR). The effects of pro-inflammatory (TNF) and metabolic (glucose, insulin) systemic factors and of immunosuppressive therapy (dexamethasone) on the myomiRs were examined in muscle cells in vitro. Results: MiR-133b was lower in the skeletal muscle of IIM patients than in that of healthy controls (P = 0.03). The levels of miR-133a, miR-1, and miR-206 were not regulated. Moreover, the plasma levels of miR-133b and miR-1 were reduced in patients with IIM compared with those in healthy controls (P <0.05). It was observed that exercise induced reciprocal regulation of specific myomiRs in the muscle and plasma of patients with IIM: it lowered miR-133b in muscle while increasing miR-133b and miR-206 in plasma. Treatment of myotubes with TNF, insulin, glucose and dexamethasone (individually) induced the downregulation of distinct myomiRs. Conclusion: Lower myomiR levels in the skeletal muscle of IIM patients might indicate reduced muscle regenerative potential in IIM, which could be linked to inflammation, metabolic dysfunction, and immunosuppressive therapy. Training-induced changes in muscle and plasma myomiRs indicate an increase in the release of myomiRs, which could contribute to the adaptive response underlying the positive systemic effects of exercise in IIM. Trial registration: ISRCTN register, https://www.isrctn.com/ ISRCTN35925199.


  • Open Access

    Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study

    by Barbora Heřmánková, Sabína Oreská, Maja Špiritović, Hana Štorkánová, Martin Komarc, Karel Pavelka, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík

    This cross-sectional study aimed to compare the sexual function (SF) and pelvic floor function of men with systemic sclerosis (SSc) with age-matched healthy controls (HC) and to identify the implications of clinical features on SF. Twenty SSc males and 20 HC aged 18-70 years completed eleven questionnaires assessing SF [International Index of Erectile Function (IIEF), Male Sexual Health Questionnaire (MSHQ)]; sexual quality of life: Sexual Quality of Life Questionnaire-Male (SQoL-M); pelvic floor function: Pelvic Floor Impact Questionnaire-Short Form 7 (PFIQ-7), fatigue, depression, physical fitness, functional disability, and quality of life. Clinical data were collected. Significantly worse SF was observed in patients (median IIEF erectile function 12 in SSc versus 29 in HC, p < 0.001), with 70% reporting erectile dysfunction (ED) compared to 15% in HC. However, no significant difference was observed regarding pelvic floor function (median PFIQ7 8.8 in SSc versus 7.0 in HC, p = 0.141). Impaired SF was associated with higher disease activity, increased systemic inflammation, more pronounced fatigue, reduced physical fitness, severe depression, impaired overall quality of life, dyspepsia, and arthralgias (p < 0.05 for all). Sexual dysfunction is highly prevalent in our SSc patients, whereas pelvic floor dysfunction is unlikely to be associated with these problems.


  • Open Access

    Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650

    by Hana Štorkánová, Lenka Štorkánová, Adéla Navrátilová, Viktor Bečvář, Hana Hulejová, Sabína Oreská, Barbora HeřMánková, Maja Špiritović, Radim Bečvář, Karel Pavelka, et al.

  • Open Access

    S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin

    by Xiao Švec, Hana Štorkánová, Thuong Trinh-Minh, Manh Cuong Tran, Lenka Štorkánová, Hana Hulejová, Sabína Oreská, Barbora Heřmánková, Radim Bečvář, Karel Pavelka, et al.

    Objectives: Our previous studies have demonstrated that the Damage Associated Molecular Pattern (DAMP) protein, S100A4, is overexpressed in the involved skin and peripheral blood of patients with SSc. It is associated with skin and lung involvement, and disease activity. By contrast, lack of S100A4 prevented the development of experimental dermal fibrosis. Herein we aimed to evaluate the effect of murine anti-S100A4 mAb 6B12 in the treatment of preestablished experimental dermal fibrosis. Methods: The effects of 6B12 were assessed at therapeutic dosages in a modified bleomycin-induced dermal fibrosis mouse model by evaluating fibrotic (dermal thickness, proliferation of myofibroblasts, hydroxyproline content, phosphorylated Smad3-positive cell count) and inflammatory (leukocytes infiltrating the lesional skin, systemic levels of selected cytokines and chemokines) outcomes, and transcriptional profiling (RNA sequencing). Results: Treatment with 7.5 mg/kg 6B12 attenuated and might even reduce pre-existing dermal fibrosis induced by bleomycin as evidenced by reduction in dermal thickness, myofibroblast count and collagen content. These antifibrotic effects were mediated by the downregulation of TGF-β/Smad signalling and partially by reducing the number of leukocytes infiltrating the lesional skin and decrease in the systemic levels of IL-1α, eotaxin, CCL2 and CCL5. Moreover, transcriptional profiling demonstrated that 7.5 mg/kg 6B12 also modulated several profibrotic and proinflammatory processes relevant to the pathogenesis of SSc. Conclusion: Targeting S100A4 by the 6B12 mAb demonstrated potent antifibrotic and anti-inflammatory effects on bleomycin-induced dermal fibrosis and provided further evidence for the vital role of S100A4 in the pathophysiology of SSc.


  • Open Access

    Cardiovascular risk in myositis patients compared with the general population

    by Sabina Oreska, Hana Storkanova, Aneta Pekacova, Jaroslav Kudlicka, Vladimir Tuka, Ondrej Mikes, Zdislava Krupickova, Martin Satny, Eva Chytilova, Jan Kvasnicka, et al.

    We aimed to evaluate cardiovascular (CV) risk in patients with idiopathic inflammatory myopathies (IIM) compared with healthy controls (HC) and to assess its association with disease-specific features. Ninety IIM patients and 180 age-/sex-matched HC were included. Subjects with a history of CV disease (angina pectoris, myocardial infarction and cerebrovascular/peripheral arterial vascular events) were excluded. All participants were prospectively recruited and underwent examinations of carotid intima–media thickness (CIMT), pulse wave velocity (PWV), ankle-brachial index (ABI), and body composition. The risk of fatal CV events was evaluated by the Systematic COronary Risk Evaluation (SCORE) and its modifications. Compared with HC, IIM patients had a significantly higher prevalence of traditional CV risk factors, carotid artery disease (CARD), abnormal ABI and PWV. After propensity score matching (using traditional CV risk factors), the prevalence of CARD and pathological PWV remained significantly higher in IIM than HC. No significant difference in SCORE was observed. The most unfavourable CV risk profile was observed in patients with necrotizing myopathy, especially in statin-induced anti-HMGCR+ patients. The calculated CV risk scores by SCORE, SCORE2 and SCORE multiplied by the coefficient 1.5 (mSCORE) were reclassified according to CIMT and the presence of carotid plaques. SCORE was demonstrated to be most inaccurate in predicting CV risk in IIM. Age, disease activity, lipid profile, body composition parameters and blood pressure were the most significant predictors of CV risk in IIM patients. Significantly higher prevalence of traditional risk factors and subclinical atherosclerosis was observed in IIM patients compared with HC.


  • Open Access

    Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study

    by Barbora Heřmánková, Maja Špiritović, Sabína Oreská, Hana Štorkánová, Heřman Mann, Karel Pavelka, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík

    Introduction Systemic sclerosis (SSc) and idiopathic inflammatory myopathies (IIM) are very rare rheumatic diseases burdened by a high prevalence of sexual dysfunctions. However, no specific treatment has been proposed to date. To our knowledge, this is the first (pilot) study aiming to investigate the effect of an 8-week tailored physiotherapy program on the sexual health of women with SSc and IIM. Methods In total, 12 women with SSc and 4 women with IIM were enrolled in the study. Based on the patients’ capability to participate in the program, they were divided into an intervention group (IG) (mean ± SD age 46.8 ± 8.6 years) and a control group (CG) (mean ± SD age 46.3 ± 8.5 years). IG underwent the 8-week program (1 h of supervised physiotherapy twice weekly), whereas CG received no physiotherapy. At weeks 0 and 8, all patients filled in questionnaires assessing sexual function (Female Sexual Function Index [FSFI], Brief Index of Sexual Functioning for Women [BISF-W]), sexual quality of life (Sexual Quality of Life-Female [SQoL-F]), functional ability (Health Assessment Questionnaire [HAQ]), quality of life (Medical Outcomes Short Form-36 [SF-36]), and depression (Beck’s Depression Inventory-II [BDI-II]). The changes were analyzed with two-way ANOVA and Friedmann’s test. Results Compared to the statistically significant deterioration in CG over weeks 0–8, we found statistically significant improvements in the total scores of FSFI and BISF-W, and some of their domains, functional status, and the physical component of quality of life. Conclusion Our 8-week physiotherapy program not only prevented the natural course of progressive deterioration of functional ability but also led to a significant improvement in sexual function and quality of life in women with SSc and IIM. However, due to the lack of randomization and a relatively small sample size resulting from the strict inclusion criteria, further validation of our results is needed. Trial registration number: ISRCTN91200867 (prospectively registered).


  • Open Access

    Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects

    by Xiao Švec, Hana Štorkánová, Maja Špiritović, Kryštof Slabý, Sabína Oreská, Aneta Pekáčová, Barbora Heřmánková, Kristýna Bubová, Petr Česák, Haya Khouri, et al.

    Compelling evidence supports the health benefits of physical exercise on the immune system, possibly through the molecules secreted by the skeletal muscles known as myokines. Herein, we assessed the impact of exercise interventions on plasma Heat shock protein 90 (Hsp90) levels in 27 patients with idiopathic inflammatory myopathies (IIM) compared with 23 IIM patients treated with standard-of-care immunosuppressive therapy only, and in 18 healthy subjects undergoing strenuous eccentric exercise, and their associations with the traditional serum markers of muscle damage and inflammation. In contrast to IIM patients treated with pharmacotherapy only, in whom we demonstrated a significant decrease in Hsp90 over 24 weeks, the 24-week exercise program resulted in a stabilization of Hsp90 levels. These changes in Hsp90 levels were associated with changes in several inflammatory cytokines/chemokines involved in the pathogenesis of IIM or muscle regeneration in general. Strenuous eccentric exercise in healthy volunteers induced a brief increase in Hsp90 levels with a subsequent return to baseline levels at 14 days after the exercise, with less pronounced correlations to systemic inflammation. In this study, we identified Hsp90 as a potential myokine and mediator for exercise-induced immune response and as a potential biomarker predicting improvement after physiotherapy in muscle endurance in IIM.


  • Open Access

    Comparison of cardiovascular risk in idiopathic inflammatory myopathy with general population – Preliminary data from a single-centre cross-sectional study

    by S. Oreská, H. Storkanova, M. Spiritovic, B. Hermankova, P. Cesak, J. Kudlicka, V. Tuka, O. Mikes, M. Satny, E. Chytilova, et al.